OPANA (Endo Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the OPANA drug offered from Endo Pharmaceuticals, Inc.. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Endo Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Oxymorphone Hydrochloride |
SUBSTANCE NAME: | OXYMORPHONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2006-06-26 |
END MARKETING DATE: | 0000-00-00 |
OPANA HUMAN PRESCRIPTION DRUG Details:
Item Description | OPANA from Endo Pharmaceuticals, Inc. |
LABELER NAME: | Endo Pharmaceuticals, Inc. |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2006-06-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63481-612_a1325ee8-019e-4531-b3ee-e023cb03c72c |
PRODUCT NDC: | 63481-612 |
APPLICATION NUMBER: | NDA021611 |
Other OXYMORPHONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: